Enhanced response rate to pegylated liposomal doxorubicin in high grade serous ovarian carcinomas harbouring BRCA1 and BRCA2 aberrations.
about
Enhanced response rate to pegylated liposomal doxorubicin in high grade serous ovarian carcinomas harbouring BRCA1 and BRCA2 aberrations.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Enhanced response rate to pegy ...... g BRCA1 and BRCA2 aberrations.
@en
Enhanced response rate to pegy ...... g BRCA1 and BRCA2 aberrations.
@nl
type
label
Enhanced response rate to pegy ...... g BRCA1 and BRCA2 aberrations.
@en
Enhanced response rate to pegy ...... g BRCA1 and BRCA2 aberrations.
@nl
prefLabel
Enhanced response rate to pegy ...... g BRCA1 and BRCA2 aberrations.
@en
Enhanced response rate to pegy ...... g BRCA1 and BRCA2 aberrations.
@nl
P2093
P2860
P50
P1433
P1476
Enhanced response rate to pegy ...... ng BRCA1 and BRCA2 aberrations
@en
P2093
Alison M Meynert
Colin A Semple
Fiona Nussey
Mark J Arends
Melanie Mackean
Michael Churchman
Tzyvia Rye
P2860
P2888
P356
10.1186/S12885-017-3981-2
P407
P577
2018-01-03T00:00:00Z
P6179
1100167723